Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Foture Biotechnology is a high-tech enterprise based in China that specializes in the research, development, and production of biological reagents for molecular diagnostics and life science research. The company offers a comprehensive portfolio of products, including high-performance enzymes, nucleic acid purification kits, and PCR-based detection systems for human and animal health. Foture Biotechnology is recognized for its expertise in providing raw materials and finished kits for the IVD industry, particularly in the detection of infectious diseases like COVID-19 and African Swine Fever. Their facilities are equipped for large-scale production of recombinant proteins and molecular biology tools, supporting both clinical diagnostics and academic research. The company maintains high quality standards and serves a global customer base of diagnostic manufacturers and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Foture Biotechnology.